Last edition
News about
Through the partnership among Sai Life Sciences, Agility Life Sciences and Centrix Pharma Solutions, customers will have access to integrated drug substance and drug product development, helping them move efficiently from pre-clinical studies to First-In-Human (FIH) clinical trials and beyond.
Lumen Bioscience Strengthens Leadership Team to Advance Oral Biologics Pipeline
US-based clinical-stage biotech Lumen Bioscience, which develops orally delivered biologics, has announced key leadership enhancements as it advances its portfolio toward commercial launch.
Revolutionising Mammography: BPL MedTech Brings LILAC for Faster, Safer Breast Cancer Screening
BPL Medical Technologies is committed to making breast cancer screening a regular part of women’s healthcare by offering LILAC, an advanced digital mammography unit.
Enzene Integrates Virtuosi to Develop Globally Competitive Pharmaceutical Workforce
With this collaboration, Enzene becomes the first Indian company to partner with Virtuosi —marking a major milestone in building a fully skilled and globally competitive pharmaceutical workforce.
BD and Opentrons Collaborate to Automate Single-Cell Multiomics Workflows
BD (Becton, Dickinson and Company) and Opentrons Labworks, Inc. have entered into a multi-year collaboration to accelerate advances in single-cell multiomics research by integrating robotic automation into critical laboratory workflows.
Meril Healthcare Authorises Shukra Pharmaceuticals for Defence Robotic Surgery Projects
Shukra Pharmaceuticals has announced that it has received a letter of authorisation from Meril Healthcare for the “Robotic Assisted Surgery System for Orthopedics” projects at the Directorate General Armed Forces Medical Services (DGAFMS) and INHS Asvini, Colaba, Mumbai (Maharashtra).
Novo Nordisk Cuts Manufacturing Jobs in USA as Global Restructuring Gains Pace
Novo Nordisk has cut production-line jobs at one of its major manufacturing sites in the USA as part of a broader global restructuring effort.
Sanofi and Partners Report Positive Phase 2 Results for AlphaMedix in Advanced GEP-NETs
AlphaMedix, which is developed by Orano Med and RadioMedix and now licensed to Sanofi, achieved all primary efficacy endpoints in the phase 2 study, demonstrating clinically meaningful benefits in patients with gastroenteropancreatic neuroendocrine tumours.
Daiichi Sankyo Files sNDA in Japan for ENHERTU Plus Pertuzumab in HER2-Positive Breast Cancer
Daiichi Sankyo has filed a supplemental NDA in Japan for ENHERTU plus Pertuzumab in HER2-positive breast cancer. If approved, this therapy could enter the first-line metastatic setting and has the potential to become a new standard of care.
<br />
UK Halves Clinical Trial Approval Times Through Major Digital Reforms
Backed by major reforms and new digital platforms at the Medicines and Healthcare products Regulatory Agency (MHRA), the UK has reduced the average clinical trial approval time by more than half — from 91 days to just 41 days.
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy